SCM
ABBV icon

Stellar Capital Management’s AbbVie ABBV Stock Holding History

Stellar Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$426K Hold
4,344
– – 0.29% 54
2020
Q1 		$331K Buy
+4,344
New +$370K 0.27% 61
2018
Q4 		– Sell
-2,156
Closed -$204K – 82
2018
Q3 		$204K Sell
2,156
-39
-2% -$3.7K 0.13% 82
2018
Q2 		$203K Hold
2,195
– – 0.13% 79
2018
Q1 		$208K Buy
+2,195
New +$241K 0.13% 79

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Stellar Capital Management's ABBV Position: Q2 2020 in Review

Stellar Capital Management held its AbbVie (ABBV) position steady in Q2 2020 at 4,344 shares worth $426K. The position accounts for 0.29% of the portfolio, ranked #54.

Stellar Capital Management first reported a position in ABBV in Q1 2018 and has held it in 5 quarters since. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Stellar Capital Management held 4,344 shares of AbbVie worth $426K as of Q2 2020.
  • Stellar Capital Management left its AbbVie share count unchanged in Q2 2020.
  • AbbVie made up 0.29% of Stellar Capital Management's portfolio in Q2 2020, its #54 holding.
  • Stellar Capital Management first reported a position in AbbVie in Q1 2018 and has held it in 5 quarters since.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Stellar Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.